AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23644819 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid biomarker levels (total tau, phosphorylated tau [181P], amyloid beta 1‐42)
Number of subjects: 403
Study 23644819 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid biomarker levels (phosphorylated tau/total tau, phosphorylated tau/amyloid beta)
Number of subjects: 403
Study 23644819 — intervention group
Group type: COMPARATOR
Intervention: Medications (deprenyl and/or tocopherol)
Number of subjects: 403
Study 23644819 — intervention group
Group type: EXPERIMENTAL
Intervention: Total tau or total tau/amyloid beta levels
Number of subjects: 403
Study 21336109 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue therapy (including prone positioning, inhaled vasodilators, high-frequency ventilation, extracorporeal membrane oxygenation)
Number of subjects: 2632
Study 21336109 — intervention group
Group type: COMPARATOR
Intervention: Prone positioning
Number of subjects: 2632
Study 19521298 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 7.5 mg/h
Number of subjects: 60
Study 19521298 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 12.5 mg/h
Number of subjects: 60
Study 19521298 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 17.5 mg/h
Number of subjects: 60
Study 19521298 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study 17584813 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing intervention (one-month duration)
Number of subjects: 41
Study 15002318 — intervention group
Group type: EXPERIMENTAL
Intervention: berlition 300 oral
Number of subjects: 56
Study 15002318 — intervention group
Group type: COMPARATOR
Intervention: vitamin B1
Number of subjects: 56
Study 11463549 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMLR) plus standard medical management
Number of subjects: 188
Study 11463549 — intervention group
Group type: COMPARATOR
Intervention: Medical management alone
Number of subjects: 188
Study 10188753 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexercise carbohydrate (CHO) containing breakfast (100 g CHO) 3 h before exercise
Number of subjects: 7
Study 10188753 — intervention group
Group type: COMPARATOR
Intervention: Overnight fast (FASTED)
Number of subjects: 7
Study 7573564 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of maximal cycle ergometry (exercise)
Number of subjects: 7
Study 7573564 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise after HDT)
Number of subjects: 7
Study 7573564 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 7
Study 7573564 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 7
Study 2186623 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% podofilox solution
Number of subjects: 38
Study 2186623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 556536 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposition mesocaval shunt
Number of subjects: 2
Study 556536 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposition splenocaval shunt
Number of subjects: 2
Study 556536 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposition mesorenal shunt
Number of subjects: 2
Study 29958027 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimicronutrient syrup
Number of subjects: 90
Study 29958027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplements (nine snack recipes rich in micronutrients)
Number of subjects: 90
Study 29958027 — intervention group
Group type: COMPARATOR
Intervention: DM controls
Number of subjects: 90
Study 29958027 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 90
Study 29958027 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (DM controls) vs Group 3 (dietary supplements)
Number of subjects: 90
Study 28435031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating-mesh-nebulizer (Aerogen Solo; VMN) with humidification
Number of subjects: 72
Study 28435031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating-mesh-nebulizer (Aerogen Solo; VMN) without humidification
Number of subjects: 72
Study 28435031 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered-dose-inhaler with AeroChamber Vent (MDI-AV) with humidification
Number of subjects: 72
Study 28435031 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered-dose-inhaler with AeroChamber Vent (MDI-AV) without humidification
Number of subjects: 72
Study 28435031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycare jet-nebulizer (JN) with humidification
Number of subjects: 72
Study 28435031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycare jet-nebulizer (JN) without humidification
Number of subjects: 72
Study 26040200 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP) 500 mg ml(‐1) + EDTA
Number of subjects: 24
Study 26040200 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP) 1 mg ml(‐1) + EDTA
Number of subjects: 24
Study 26040200 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP) 500 mg ml(‐1)
Number of subjects: 24
Study 26040200 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP) 1 mg ml(‐1)
Number of subjects: 24
Study 26040200 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA only
Number of subjects: 24
Study 26040200 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 24
Study 22441962 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (submaximal treadmill walking, 30 min daily, 3 times a week for 6 weeks)
Number of subjects: 36
Study 22441962 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vest exercise (same as aerobic but with a weighted vest of 4-8% of body weight for 6 weeks)
Number of subjects: 36
Study 22441962 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 36
Study 22441962 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vest exercise
Number of subjects: 36
Study 21309695 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (15 mg every morning or two times per day as glycinate)
Number of subjects: 52
Study 21309695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 21309695 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg/day)
Number of subjects: 52
Study 21309695 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (15 mg b.i.d.)
Number of subjects: 52
Study 19111111 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) for acute respiratory failure (ARF)
Number of subjects: 0
Study 17098669 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation
Number of subjects: 61
Study 17098669 — intervention group
Group type: COMPARATOR
Intervention: Nadolol plus isosorbide-5-mononitrate (ISMN)
Number of subjects: 61
Study 14531256 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia (sevoflurane, nitrous oxide in oxygen)
Number of subjects: 40
Study 14531256 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (0.5% bupivacaine)
Number of subjects: 40
Study 10727076 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (21g x d(‐1))
Number of subjects: 14
Study 8704699 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow stored for 2 years or more
Number of subjects: 36
Study 8704699 — intervention group
Group type: COMPARATOR
Intervention: Control group (selected by diagnosis and date of storage)
Number of subjects: 36
Study 8704699 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow samples cryopreserved for a median of 4.4 years (range 2.0-7.8)
Number of subjects: 36
Study 1496149 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating air mattress
Number of subjects: 57
Study 1496149 — intervention group
Group type: COMPARATOR
Intervention: Static air mattress
Number of subjects: 57
Study 1496149 — intervention group
Group type: COMPARATOR
Intervention: Water mattress overlay
Number of subjects: 57
Study 1496149 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-Fowler's position
Number of subjects: 57
Study 1496149 — intervention group
Group type: COMPARATOR
Intervention: Recumbent position
Number of subjects: 57
Study 1496149 — intervention group
Group type: COMPARATOR
Intervention: Pressure sores incidence
Number of subjects: 57
Study 6648604 — intervention group
Group type: EXPERIMENTAL
Intervention: Care groups intervention
Number of subjects: 0
Study 6648604 — intervention group
Group type: COMPARATOR
Intervention: Control villages without care groups
Number of subjects: 0
Study 3541166 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 10
Study 3541166 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 10
Study 31175696 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide 6% solution under occlusion for one hour daily for 6 weeks
Number of subjects: 145
Study 31175696 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide 3% solution
Number of subjects: 145
Study 31175696 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 0.9% as a placebo
Number of subjects: 145
Study 29428121 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention (psychiatry, psychology, medicine, occupational therapy, neuropsychology, and family therapy)
Number of subjects: 302
Study 29428121 — intervention group
Group type: COMPARATOR
Intervention: Traditional intervention (psychiatry and medicine only)
Number of subjects: 302
Study 27450909 — intervention group
Group type: EXPERIMENTAL
Intervention: Text Message Alcohol Program (TMAP)
Number of subjects: 60
Study 27450909 — intervention group
Group type: COMPARATOR
Intervention: Control (general motivational text messages)
Number of subjects: 60
Study 24901753 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 48
Study 24901753 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 48
Study 24901753 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 22049336 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (pain)
Number of subjects: 11
Study 22049336 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 11
Study 19656577 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole (n=373)
Number of subjects: 741
Study 19656577 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=368)
Number of subjects: 741
Study 18712195 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiskill club (n = 19 children)
Number of subjects: 34
Study 18712195 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15 children)
Number of subjects: 34
Study 16433205 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (CE) 200 mg
Number of subjects: 29
Study 16433205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 12732998 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (250 microg/hr for 7 days postoperatively)
Number of subjects: 54
Study 12732998 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline for 7 days postoperatively)
Number of subjects: 54
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone
Number of subjects: 0
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Class III agents
Number of subjects: 0
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide
Number of subjects: 0
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 0
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Azimilide
Number of subjects: 0
Study 10666660 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone, tedisamal, trecetilide
Number of subjects: 0
Study 9016418 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin recommended for patients with nonrheumatic atrial fibrillation
Number of subjects: 189
Study 9016418 — intervention group
Group type: COMPARATOR
Intervention: Warfarin for 85-year-old patients
Number of subjects: 189
Study 9016418 — intervention group
Group type: COMPARATOR
Intervention: Warfarin for patients with bleeding risk factors
Number of subjects: 189
Study 9016418 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin for patients with a recent stroke
Number of subjects: 189
Study 9016418 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin prescription by physicians with good experience
Number of subjects: 189
Study 9016418 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin prescription by physicians with favorable opinions
Number of subjects: 189
Study 9016418 — intervention group
Group type: COMPARATOR
Intervention: Warfarin prescription despite good experience and favorable opinions
Number of subjects: 189
Study 1611986 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (Dormicum 7.5 mg)
Number of subjects: 0
Study 6580807 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 1884
Study 6580807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1884
Study 30904663 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI-noise setting
Number of subjects: 50
Study 30904663 — intervention group
Group type: COMPARATOR
Intervention: silent setting
Number of subjects: 50
Study 29574439 — intervention group
Group type: EXPERIMENTAL
Intervention: Early supervised structured exercise programme delivered by physiotherapists, incorporating shoulder-specific exercises, general physical activity, and behavioural strategies.
Number of subjects: 350
Study 29574439 — intervention group
Group type: COMPARATOR
Intervention: Best practice usual care only (control group).
Number of subjects: 350
Study 27169493 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal O2 therapy
Number of subjects: 12
Study 27169493 — intervention group
Group type: EXPERIMENTAL
Intervention: PETCO2
Number of subjects: 12
Study 24450992 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Disease Self‐Management Program (CDSMP; n = 101)
Number of subjects: 376
Study 24450992 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self‐care software on a personal digital assistant (PDA; n = 81)
Number of subjects: 376
Study 24450992 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CDSMP + PDA (n = 99)
Number of subjects: 376
Study 24450992 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control; n = 95)
Number of subjects: 376
Study 22834932 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser + SRP (photoablative intra/extra-pocket de-epithelization with diode laser (λ = 810 nm) and multiple photodynamic treatments (mean ± SD: 3.7 ± 2.4 applications) using diode laser (λ = 635 nm) and 0.3% methylene blue as photosensitizer)
Number of subjects: 26
Study 22834932 — intervention group
Group type: COMPARATOR
Intervention: Sham-laser treatment + SRP
Number of subjects: 26
Study 20140794 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 1305
Study 20140794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1305
Study 18681820 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (up to 50 or 100 mg/day)
Number of subjects: 9
Study 18681820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 15942765 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Training (CT)
Number of subjects: 8
Study 12840633 — intervention group
Group type: EXPERIMENTAL
Intervention: Two bouts of exercise (AM-EX and PM-EX)
Number of subjects: 10
Study 12840633 — intervention group
Group type: EXPERIMENTAL
Intervention: PM exercise
Number of subjects: 10
Study 12840633 — intervention group
Group type: COMPARATOR
Intervention: Control (CN)
Number of subjects: 10
Study 11006058 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive and estrogen replacement therapy users
Number of subjects: 1027
Study 11006058 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 1027
Study 11006058 — intervention group
Group type: COMPARATOR
Intervention: Postmenopausal women
Number of subjects: 1027
Study 9148197 — intervention group
Group type: EXPERIMENTAL
Intervention: Directing attention to the left ear (DL) during the CVT test
Number of subjects: 16
Study 9148197 — intervention group
Group type: EXPERIMENTAL
Intervention: Directing attention to the right ear (DR) during the CVT test
Number of subjects: 16
Study 9148197 — intervention group
Group type: EXPERIMENTAL
Intervention: Directing attention to the left ear (DL) during the FDWT test
Number of subjects: 16
Study 9148197 — intervention group
Group type: EXPERIMENTAL
Intervention: Directing attention to the right ear (DR) during the FDWT test
Number of subjects: 16
Study 9148197 — intervention group
Group type: COMPARATOR
Intervention: Fused dichotic words test (FDWT)
Number of subjects: 16
Study 9148197 — intervention group
Group type: COMPARATOR
Intervention: CV syllables dichotic listening test (CVT)
Number of subjects: 16
Study 1507038 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (new electric toothbrush)
Number of subjects: 96
Study 1507038 — intervention group
Group type: COMPARATOR
Intervention: Control hand group (manual toothbrush)
Number of subjects: 96
Study 1507038 — intervention group
Group type: COMPARATOR
Intervention: Control electric group (electric toothbrush)
Number of subjects: 96
Study 1507038 — intervention group
Group type: EXPERIMENTAL
Intervention: All three groups (experimental, control hand, control electric)
Number of subjects: 96
Study 6322565 — intervention group
Group type: EXPERIMENTAL
Intervention: MK 421
Number of subjects: 48
Study 6322565 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 48
Study 30723840 — intervention group
Group type: EXPERIMENTAL
Intervention: EAMD + Cal (increased caloric intake)
Number of subjects: 118
Study 30723840 — intervention group
Group type: COMPARATOR
Intervention: EAMD Control
Number of subjects: 118
Study 30723840 — intervention group
Group type: COMPARATOR
Intervention: OV Control
Number of subjects: 118
Study 29198064 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilisate (120-μg)
Number of subjects: 18
Study 29198064 — intervention group
Group type: COMPARATOR
Intervention: Tablet (200-μg)
Number of subjects: 18
Study 27981529 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/d regular oral intake of aspirin
Number of subjects: 98
Study 27981529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 24733781 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy M technique hand massage
Number of subjects: 117
Study 24733781 — intervention group
Group type: EXPERIMENTAL
Intervention: M technique without aromatherapy
Number of subjects: 117
Study 24733781 — intervention group
Group type: COMPARATOR
Intervention: Nurse presence
Number of subjects: 117
Study 22227725 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat emulsion with part of the lipid replaced by fish oil (Group B, n = 18)
Number of subjects: 38
Study 22227725 — intervention group
Group type: COMPARATOR
Intervention: Mixture of soybean and medium-chain triglyceride oils (Group A, n = 12)
Number of subjects: 38
Study 20195825 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerarin
Number of subjects: 18
Study 18547179 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermicol‐P35
Number of subjects: 149
Study 18547179 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) filler Restylane
Number of subjects: 149
Study 15740537 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment duration of 48 weeks for cirrhotic patients
Number of subjects: 0
Study 15740537 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment duration of 48 weeks for noncirrhotic genotype 1 or 4 patients with elevated alanine aminotransferase levels
Number of subjects: 0
Study 15740537 — intervention group
Group type: COMPARATOR
Intervention: Treatment duration of 24 weeks for noncirrhotic patients with genotype 2 or 3
Number of subjects: 0
Study 11788628 — intervention group
Group type: EXPERIMENTAL
Intervention: GH + LHRH analog (LHRH‐A)
Number of subjects: 17
Study 11788628 — intervention group
Group type: EXPERIMENTAL
Intervention: GH alone
Number of subjects: 17
Study 10405740 — intervention group
Group type: EXPERIMENTAL
Intervention: Core-needle biopsy
Number of subjects: 132
Study 10405740 — intervention group
Group type: COMPARATOR
Intervention: Surgical biopsy
Number of subjects: 132
Study 7789344 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial interventions
Number of subjects: 62
Study 2193304 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid group (betamethasone)
Number of subjects: 0
Study 2193304 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study 365670 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone solution before peroral endoscopy
Number of subjects: 0
Study 31520445 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser (EL)
Number of subjects: 10
Study 31520445 — intervention group
Group type: EXPERIMENTAL
Intervention: gain-switched 311-nm titanium:sapphire laser (TSL)
Number of subjects: 10
Study 31590034 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise programme (n=39)
Number of subjects: 77
Study 31590034 — intervention group
Group type: COMPARATOR
Intervention: Low intensity exercise programme (n=38)
Number of subjects: 77
Study 28880867 — intervention group
Group type: EXPERIMENTAL
Intervention: THU-decitabine
Number of subjects: 25
Study 28880867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 25904273 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 K-wires and a volar semi-circular cast for the first 3 weeks followed by a removable splint for a further 3 weeks (Group I)
Number of subjects: 92
Study 25904273 — intervention group
Group type: COMPARATOR
Intervention: 2 K-wires and a below-elbow circular cast for 6 weeks postoperatively (Group II)
Number of subjects: 92
Study 24239210 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment (FEC-75 followed by paclitaxel plus trastuzumab)
Number of subjects: 282
Study 24239210 — intervention group
Group type: COMPARATOR
Intervention: Concurrent treatment (paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab)
Number of subjects: 282